For Debate: The 2023 European Society of Hypertension guidelines - cause for concern.



Shantsila, Eduard ORCID: 0000-0002-2429-6980, Beevers, D Gareth and Lip, Gregory YH ORCID: 0000-0002-7566-1626
(2024) For Debate: The 2023 European Society of Hypertension guidelines - cause for concern. Journal of hypertension, 42 (6). pp. 948-950. ISSN 0263-6352, 1473-5598

Access the full-text of this item by clicking on the Open Access link.

Abstract

Originally, the beta-blockers were equally ranked alongside the other antihypertensive drug classes. Things changed when two major long-term randomized controlled trials, ASCOT-BPLA and LIFE showed that the patients receiving the beta-blockers based regimes suffered 25-30% more strokes than those receiving a calcium channel blocker based regime or an angiotensin receptor blocker based regime. The inferiority of the beta-blockers at stroke prevention was not due to differences in blood pressure control during the follow-up period in both trials. The 2023 European Society of Hypertension (ESH) guidelines still argue in favour of beta-blockers that their clinical inferiority was simply to lesser blood pressure reduction rather than class effect. The analysis argues that the return of beta-blockers as a first-line option for the management of uncomplicated hypertension by the ESH is a cause for concern and should be reconsidered.

Item Type: Article
Uncontrolled Keywords: beta-blockers, guidelines, hypertension
Divisions: Faculty of Health & Life Sciences
Faculty of Health & Life Sciences > Inst. Life Courses & Medical Sciences
Faculty of Health & Life Sciences > Inst. Population Health
Depositing User: Symplectic Admin
Date Deposited: 15 May 2024 08:55
Last Modified: 22 May 2026 21:12
DOI: 10.1097/hjh.0000000000003733
Open Access URL: https://doi.org/10.1097/hjh.0000000000003733
Related Websites:
URI: https://livrepository.liverpool.ac.uk/id/eprint/3180975
Disclaimer: The University of Liverpool is not responsible for content contained on other websites from links within repository metadata. Please contact us if you notice anything that appears incorrect or inappropriate.